golidocitinib
T-START-M1
Phase 3 small_molecule active
Quick answer
golidocitinib for Peripheral T Cell Lymphoma is a Phase 3 program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Peripheral T Cell Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active